Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advanced Magnetic Resonance Imaging Measures of Repair in Alemtuzumab Treated Patients

NCT01307332 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT01307332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01307332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advanced Magnetic Resonance Imaging Measures of Repair in Alemtuzumab Treated Patients
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2011
Completion date
September 28, 2018
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis